Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SURGERY PARTNERS, INC.

(SGRY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 4797721 4423 723--
Entreprise Value (EV)1 2 6213 2603 9816 3816 4956 542
P/E ratio -1,97x-6,90x-9,09x-53,7x205x81,8x
Yield ------
Capitalization / Revenue 0,27x0,42x0,78x1,67x1,51x1,37x
EV / Revenue 1,48x1,78x2,14x2,86x2,64x2,40x
EV / EBITDA 11,2x12,6x15,5x19,6x17,6x15,8x
Price to Book 1,18x2,60x12,7x7,66x6,11x4,31x
Nbr of stocks (in thousands) 48 90249 29649 71987 889--
Reference price (USD) 9,7915,729,042,442,442,4
Announcement Date 03/13/201903/05/202003/10/2021---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 1 7711 8311 8602 2352 4592 721
EBITDA1 235259257325369414
Operating profit (EBIT)1 158172149313399467
Operating Margin 8,92%9,39%7,99%14,0%16,2%17,2%
Pre-Tax Profit (EBT)1 -69,254,6-18,895,5162278
Net income1 -238-110-156-56,223,545,5
Net margin -13,4%-5,98%-8,37%-2,52%0,95%1,67%
EPS2 -4,96-2,27-3,19-0,790,210,52
Dividend per Share2 ------
Announcement Date 03/13/201903/05/202003/10/2021---
1 USD in Million
2 USD
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2
Net sales1 512543559620571605
EBITDA1 62,275,976,410479,190,0
Operating profit (EBIT)1 42,046,647,111479,489,4
Operating Margin 8,20%8,58%8,42%18,3%13,9%14,8%
Pre-Tax Profit (EBT)1 11,06,109,4068,228,544,9
Net income1 -31,3-26,9-22,916,0-7,303,50
Net margin -6,11%-4,95%-4,10%2,57%-1,28%0,58%
EPS2 -0,57-0,39-0,280,16-0,090,00
Dividend per Share ------
Announcement Date 05/05/202108/04/202111/02/2021---
1 USD in Million
2 USD
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 2 1422 4882 5392 6592 7722 819
Net Cash position1 ------
Leverage (Debt / EBITDA) 9,12x9,62x9,89x8,18x7,52x6,81x
Free Cash Flow1 10555,994,4-36,410,7106
ROE (Net Profit / Equities) -7,28%-11,7%-28,8%-10,5%3,14%1,18%
Shareholders' equity1 3 2719375405357483 846
ROA (Net Profit / Asset) -5,12%---0,50%0,30%-0,10%
Assets1 4 651--11 2477 827-45 483
Book Value Per Share2 8,286,022,295,536,939,83
Cash Flow per Share2 3,012,685,06-0,201,40-
Capex1 39,873,642,959,666,578,0
Capex / Sales 2,25%4,02%2,31%2,67%2,70%2,87%
Announcement Date 03/13/201903/05/202003/10/2021---
1 USD in Million
2 USD
Key data
Capitalization (USD) 3 722 992 993
Net sales (USD) 1 860 100 000
Number of employees 9 950
Sales / Employee (USD) 186 945
Free-Float 38,7%
Free-Float capitalization (USD) 1 439 440 830
Avg. Exchange 20 sessions (USD) 24 009 140
Average Daily Capital Traded 0,64%
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA